Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

Zeneca selects new HLE inhibitor for clinical development

Nov. 6, 1997

Chiroscience develops new TNF/PDE IV inhibitors

Nov. 4, 1997

HMR claims dual H1/NK1 antagonists for allergic/inflammatory disorders

Nov. 4, 1997

rPAF-AH proceeds to phase II for asthma

Oct. 31, 1997

HMR reports dual H1/NK1 receptor antagonists

Oct. 30, 1997

Spotlight on tryptase inhibitors for asthma

Oct. 28, 1997

SciClone presents promising preclinical data for CPX at CF conference

Oct. 27, 1997

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...